Tacrolimus (FK 506) in clinical cardiac transplantation: A five-year experience

Transplantation Proceedings

Volumn 28, Issue 2, 1996, Pages 1002-1004

  Pham, S M ^a   Kormos, R L ^a   Kawai, A ^a   Murali, S ^a   Hattler, B G ^a   Demetris, A J ^a   Griffith, B P ^a  

^a Division of Urologic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; FLUDROCORTISONE; METHOTREXATE; METHYLPREDNISOLONE; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HYPERKALEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE IRRADIATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTILYMPHOCYTE SERUM; AZATHIOPRINE; COMMUNICABLE DISEASES; CORONARY DISEASE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MUROMONAB-CD3; PREDNISONE; SURVIVAL RATE; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029869255     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)